Research interpretation, not diagnosis or personal treatment advice. Urgent symptoms belong with a clinician, not a browser tab.
Performance and muscle

Creatine monohydrate

Useful evidence for strength and training support; longevity benefits would be indirect.

The 30-second verdict Creatine monohydrate has a much stronger human evidence base than most products sold under a longevity label. Its clearest benefits concern high-intensity performance and gains from resistance training. In older adults, preserving strength and lean mass is plausibly relevant to healthspan, although creatine has not been shown to extend human life.

Evidence matrix

These scores describe different evidence domains. A strong mechanism cannot compensate for missing human outcomes, and a useful clinical effect need not imply slower biological ageing.

Human clinical outcomes Moderate
Human biomarkers Moderate
Animal lifespan Preliminary
Mechanistic plausibility Strong
Safety certainty Strong
Direct longevity relevance Limited

What has been shown in humans?

Trials and reviews support improved training capacity and, when combined with resistance exercise, modest improvements in strength or lean mass in many populations. Cognitive findings are promising but less consistent and may be more apparent in older adults, vegetarians or people under sleep or metabolic stress.

What remains uncertain?

The magnitude of benefit in sedentary people, the long-term effect on disability or falls, and the populations most likely to gain cognitive benefit remain uncertain.

Doses used in research

Descriptive, not prescriptive Many studies use 3–5 g daily after an optional loading period. This is a description of common trial designs rather than personal advice.

Safety and interpretation

  • Creatine monohydrate is one of the better-studied supplements and is generally well tolerated in healthy adults at conventional study doses.
  • Serum creatinine can rise because creatine is converted to creatinine; interpretation of kidney tests may therefore require clinical context.
  • Existing kidney disease, pregnancy or complex medication use warrants individual medical advice.

Primary sources and evidence reviews

Editorial note

This dossier was last reviewed on 13 July 2026. Ratings can change when larger trials, adverse-event data or better systematic reviews appear. Corrections should alter the page rather than being buried in a social-media thread.